PACB
NASD Pacific Biosciences of California, Inc.$2.54 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.54, $0.11 below the day’s high of $2.65
- YTD change
- +35.83%
- vs 20-day SMA
- +66.72%
- vs 200-day SMA
- +61.53%
Price ranges
Price & Performance
+1.12 (+78.87%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 95.3% away from all-time highs of $53.69
- PACB is up 36% since the beginning of the year
- PACB is up 78% over the past 12 months
- PACB is up 92% over the past 1 month
- 17% of all PACB investors are betting against PACB
PACB reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +70.5%.
- Previous minute
- +$0.03
- Last hour
- +$0.01
- Last 5 days
- +60.76%
- vs 8-day SMA
- +40.14%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.